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Gulf War Syndrome: A role for organophosphate 
induced plasticity of locus coeruleus neurons
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veterans  of  the  1991  Gulf  War.  Exposure  to  prolonged  low-­level  organophosphate  insecticides  and  other  toxic  
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attention  and  emotional  response  to  stress.  Here  we  used  an  ex  vivo  rodent  model  to  identify  a  dramatic  effect  of  
chlorpyrifos  oxon  on  locus  coeruleus  noradrenergic  neuronal  activity.  Prolonged  exposure  to  chlorpyrifos  oxon  
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Gulf War deployment has been associated with an increased 
prevalence of psychological symptoms, such as anxiety and 
depression, substance use, mental disorders and a lower qual-
ity of life beginning during the war and persisting a decade 
later. In 2008, a US Government panel concluded and vali-
dated that “Gulf War syndrome” (GWS) a!icted about 25% 
of the 700,000 deployed US veterans1. Epidemiological stud-
ies indicate that repetitive low-level exposure to organophos-
phate chemicals, including the insecticide, chlorpyrifos (CP) 
was one probable causative factor in GWS2.
 CP was frequently used as an insecticide applied to 
bedding and clothing during the Gulf War.  Since the Gulf 
War the use of CP has been banned for household use in the 
US, but use and exposure remains high in agricultural com-
munities and developing countries.  Epidemiological data 
from agricultural communities that use CP regularly also 
report GWS-like symptoms.  Lasting developmental delays 
in children exposed to CP have been con"rmed along with 
a 50-75% increase in the prevalence of Attention De"cit Hy-
peractivity Disorder (ADHD) per 10 fold increase in urinary 
metabolites of CP.1,3
 CP is metabolized and excreted in urine as the tox-
ic metabolite chlorpyrifos oxon (CPO). CPO is several fold 
more potent than CP as a neurotoxin due to its irreversible 
inhibition of acetylcholinesterase (AChE) activity, a similar 
mechanism to the neurotoxin, Sarin4,5. Given the lack of a di-
rect connection between CPO and changes in neuronal func-
tion we developed an ex vivo rodent brain slice preparation 
to assess the e#ects of acute and prolonged exposure e#ects 
of CPO on the excitability of noradrenergic neurons within 
the LC. $e LC provides the sole source of noradrenaline in 
the brain and has a well-established role in mediating arousal, 
attention, anxiety and stress response1.
RESULTS
$e results show that CPO (50 uM) application to cultured 
brain slices containing the LC signi"cantly (n=12; p<0.01) re-
duced the "ring rate of putative noradrenergic neurons (!g. 
1a) recorded using extracellular loose seal patch recording at 
33°C. $e CPO-induced e#ect fully washed out a%er 30 min-
utes indicating it was not directly toxic to the brain slice.
Figure 1: (a) Acute application of  CPO reduces spontaneous action poten-
tial activity in the LC noradrenergic neurons. Loose seal extracellular patch-
clamp recordings were obtained from brain slices 250 µm thick.  CPO (50 
µm) applied for 10 minutes substantially reduced firing rate (n=12, **p < 
0.01) before being washed out for 30 minutes. (b) Three day treatment with 
CPO (10 µm) or vehicle (DMSO) elicited a rebound increased basal LC neu-
ronal activity when CPO was removed from the slice (n=10-12,**P < 0.01).
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In a second experiment (!g 1b) we tested the e#ects of pro-
longed (3 days) exposure to lower doses of CPO (10 µM). Af-
ter a 3 days of CPO and a 90-180 minutes washout period we 
observed a rebound increase in the activity of putative nor-
adrenaline neurons within the LC indicating a lasting plastic-
ity resulting from prolonged exposure to CPO. Our results 
indicate that as a model system, the LC slice cultures are ideal 
for addressing whether acute and prolonged CPO exposure 
can induce homeostatic changes in LC excitability ex vivo 
and  further identify the molecular mechanisms responsible 
for the plasticity.
DISCUSSION
We identi"ed a possible physiological mechanism underly-
ing a subset of the psychological symptoms associated with 
GWS. $is study provides the "rst evidence showing that the 
toxic metabolite CPO of the insecticide CP, alters LC norad-
renergic neural activity in a lasting manner.  Deployed Gulf 
War soldiers were overexposed to insecticides and the GWS 
symptoms are reported to be higher amongst those exposed 
to organophosphates (OP).  Government reports indicate that 
insecticides were applied on skin, clothing, in tents, sleeping 
quarters and sprayed in camp1.  To make the problem worse 
oxidative conversion of CP to the more toxic CPO occurs 
when CP comes into contact with oxidizing decontaminat-
ing cleaning and laundry products, such as bleach. $e ex-
act mechanism for how prolonged low-level exposure leads 
to psychiatric symptoms in some individuals and not others 
remains unknown.
 Recently, however, the OP metabolic pathway has 
been implicated as a genetic vulnerability factor for some 
individuals.  Studies have found that Gulf War veterans who 
became chronically ill have lower levels of the enzyme par-
oxanase I (PONI), which serves to neutralize nerve agents 
and OP compounds like CPO1.  Individual genetic polymor-
phisms in PONI may contribute to the severity of symptoms 
reported in those exposed to low-levels of OP compounds.  
$e possibility that certain individuals might be vulnerable 
to low-levels of OP insecticides is a concern from a human 
health and public policy perspective because OP pesticides 
are still widely used in agriculture communities and the devel-
oping world.  In fact, recent reports found that environmental 
CP exposure produces developmental delays in children and 
substantially increases the prevalence of ADHD1,3. In light of 
this there is an urgent need to develop better ways to test for 
OP contaminants in the environment and understand their 
physiological e#ects in model systems. 
 In the brain slice model we found robust modula-
tion of neural excitability in neurons within the LC. Acute ap-
plication of CPO produced a rapid inhibition of spontaneous 
activity followed by a prolonged excitation lasting days. Al-
though we did not assess the behavioral state of rats exposed 
to CPO, we have observed similar lasting changes in rat LC 
neural activity a%er acute and prolonged morphine exposure. 
During withdrawal from morphine there is a profound with-
drawal syndrome that is correlated with a prolonged increase 
in the excitability of LC neurons and behavioural states of 
anxiety and distress7. Future research is needed to determine 
if withdrawal from prolonged CPO exposure in vivo results in 
the same molecular mechanism underlying withdrawal and 
anxiety from morphine1.
 It is likely that pathological changes in the activity 
of LC neurons during CPO withdrawal disrupt the balance 
of noradrenaline throughout the brain and especially in brain 
regions responsive to stress. $is change in LC output may 
lead to increased susceptibility to stressful traumatic events. 
Understanding the cellular neuroadaptations in response to 
low-level CPO exposure in the LC neurons is important for 
developing treatments with the potential to reverse pathologi-
cal plasticity of LC excitability and the psychological states 
associated with it.
METHODS
Slice Cultures and Recordings
Slice cultures were prepared using the traditional method 
"rst introduced by Stoppinni et al. (1991)6. Acute LC slices 
were trimmed as thin as possible  and maintain for 3d in an 
incubator at 33°C. A Gibco MEM medium consisting of 30 
mM HEPES, 20 mM D-glucose, 5% B27, 5.0 mM L-glutamine 
and 25 U/ml streptomycin/penicillin based on previous LC 
culture which proved sucessful6. Slice cultures were measured 
in aCSF with a DigiData 1233A and pClamp8 (axon instru-
ments). For expanded methods and recordings please see 
http://www.neurocloud.org/nature-precedings/cao/ .
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